Thermo Fisher Scientific | TMO - Gewinn Vor Steuern

Aktienkurs
478.96
Täglich Wechseln
12.70 2.72%
Monatlich
-2.56%
Jährlich
14.07%
Q2 Prognose
459.66




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 442M 1000K 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Boston Scientific USD 700M 238M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -230M 77M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
General Electric Aerospace USD 2.2B 654M 2026-03
Henry Schein USD 137M 16M 2025-09
Illumina USD 377M 157M 2025-12
Intuitive Surgical USD 955.6M 100.4M 2025-12
IQVIA Holdings USD 537M 5.62B 2025-12
Laboratory Of America USD 190.6M 146.4M 2025-12
Medtronic USD 2.1B 224M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Olympus JPY 22.13B 5.77B 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Stryker USD 1.7B 676M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 40.63M 21.74M 2025-12
Waters USD 170.12M 7.57M 2025-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12